Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches

Inflammatory bowel disease (IBD) is a complex heterogeneous disorder defined by recurring chronic inflammation of the gastrointestinal tract, attributed to a combination of factors including genetic susceptibility, altered immune response, a shift in microbial composition/microbial insults (infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Reilly, Catherine, Mills, Susan, Rea, Mary C., Lavelle, Aonghus, Ghosh, Subrata, Hill, Colin, Ross, R. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615213/
https://www.ncbi.nlm.nih.gov/pubmed/37849974
http://dx.doi.org/10.20517/mrr.2023.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615213/
https://www.ncbi.nlm.nih.gov/pubmed/37849974
http://dx.doi.org/10.20517/mrr.2023.41

Ejemplares similares